Skip to main content


Episode 10: Disease-modifying therapy for type 1 diabetes

Reducing the burden of type 1 diabetes

Despite many recent advances in its management, type 1 diabetes remains a burden for those living with the condition.

Prof. Chantal Mathieu explains the progress being made with disease-modifying therapy for type 1 diabetes and how it has the potential to transform the current treatment landscape.

Listen now

Stay up to date with our podcasts

Medicine Matters keeps practicing doctors informed of key clinical developments, discusses controversial issues in medicine, and helps doctors be sure that their patient care is up to date.

More episodes from Medicine Matters

Episode 0: Introducing Medicine Matters

In this episode, Dr. Jane Godsland & Dr. Erik Heintz introduce the new platform and podcast. 

» Listen now

Episode 1: From Gray's to Google

We talk to Dr. Nathalie van Havre and Dr. Elsbeth Headley about ongoing medical education in the digital age. 

» Listen now

Episode 2: Progress in PARP inhibitors

In this episode, Dr. Elena Castro takes us through the latest evidence for PARP inhibitors and their combinations in this setting.

» Listen now

Episode 3: Unravelling resistant hypertension

In this episode, Professors Morris Brown and Bryan Williams debate the causes of resistant hypertension and explore novel treatment options. 

» Listen now

Episode 4: Stem cell therapy for PD

Prof. Malin Parmar explains why stem cell therapy is such a good option for patients with Parkinson’s disease and how its safety is being tested in the STEM-PD trial.

» Listen now

Episode 5: Next-generation sequencing in cancer

Professor Andrew Beggs discusses best practice in the use of next-generational sequencing within thyroid and non-small cell lung cancers

Supported by: Illumina, Inc., and Eli Lilly and Company

» Listen now

Episode 6: OCT for coronary imaging

Drs Niels Holm and Lene Andreasen bring us up to speed with the latest evidence, and explore whether we should expect to see this technology in use in our clinics in the future.

» Listen now

Episode 7: A deep dive into ADAURA

A conversation with Dr. Luis Paz-Ares about the key questions raised by the ADAURA trial of adjuvant osimertinib in early-stage NSCLC.

» Listen now

Episode 8: AI in stroke

Prof. Susanne Wegener discusses her team’s work to develop deep learning models that outperform neurologists in predicting patients’ clinical outcomes after stroke.

» Listen now

Episode 9: The gut microbiome and CAR T-cell therapy

Prof. Marion Subklewe explores the interplay between the gut microbiota and the efficacy and safety of CAR T-cell therapy in people with hematologic malignancies.

» Listen now

Subscribe to Medicine Matters via...

Adis Journal Podcasts

Navigating the treatment of renal cell carcinoma: Insights on the current treatment landscape and managing patient health

In recent years, tremendous efforts have been made in the medical treatment of metastatic renal cell carcinoma (mRCC), with immune-oncological combinations standing as the current standard of care in the first-line setting of mRCC. In these podcasts, expert authors discuss the current treatment landscape for these new therapies and discuss what should be taken into account when choosing the most appropriate treatment for their patients so as to balance outcomes, adverse events and quality of life.

Supported by: Eisai Europe Limited

Listen now

Using CGM to optimize type 2 diabetes management with non-intensive insulin treatment in primary care

With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report. 

Supported by: Abbott Diabetes Care

Listen now